INMB
Companies
NASDAQ
Inmune Bio Inc.
Health Care
$7.24
Price Chart
Overview
About INMB
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
Market Cap
$173.3M
Volume
1.9M
Avg. Volume
1.8M
P/E Ratio
-3.764706
Dividend Yield
0.00%
Employees
15.0
Company Information
Risk & Correlation Analysis
Market Correlation
N/A
N/A
Volatility
N/A
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, INMB shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$173.3M
Volume1.9M
P/E Ratio-3.76
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2025Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025